Screening of BRCA1 and BRCA2 germline mutations in unselected triple‐negative breast cancer patients: A series from north of Morocco-Reference-Cited by-同舟云学术

Screening of BRCA1 and BRCA2 germline mutations in unselected triple‐negative breast cancer patients: A series from north of Morocco

Published:2020-03 Issue:1 Volume:9 Page:43-48
ISSN:2642-2514
Container-title:Precision Medical Sciences
language:en
Short-container-title:Precision Medical Sciences

Author:

Mansouri Mohammed¹²,Derkaoui Touria¹^ORCID,Bakkach Joaira¹,Loudiyi Ali²,Ghailani Nourouti Naima¹,Barakat Amina¹,Villarreal Jaime Martínez³,Bringas Carlos Cortijo³,Bennani Mechita Mohcine¹

Affiliation:

1. Laboratory of Biomedical Genomics and Oncogenetics, Faculty of Sciences and Techniques of TangierAbdelmalek Essaâdi University Tetouan Morocco

2. Oncology Clinic Al Amal of Tangier Tangier Morocco

3. Genetracer Biotech Laboratory Santander Spain

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prm2.12009

Reference37 articles.

1. Triple-Negative Breast Cancer

2. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype

3. Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence

4. Prevalence of BRCA1 mutations among 284 women with triple‐negative breast cancer;Fostira F;J Clin Oncol,2010

5. Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased prevalence of the founder BRCA1 c.5309G>T and recurrent BRCA2 c.1310_1313delAAGA mutations in breast cancer families from Northerstern region of Morocco: evidence of geographical specificity and high relevance for genetic counseling;BMC Cancer;2023-04-13

2. A comprehensive survey on spectrum of BRCA1 and BRCA2 pathogenic variants in breast and ovarian cancer;Immunological Implications and Molecular Diagnostics of Genitourinary Cancer;2023

3. Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer;Frontiers in Oncology;2022-07-18

4. Prevalence of Clinically Relevant Germline BRCA Variants in a Large Unselected South African Breast and Ovarian Cancer Cohort: A Public Sector Experience;Frontiers in Genetics;2022-04-08

5. Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa;BMC Cancer;2022-02-25